Après délibération, le collège de la Haute Autorité de santé, en sa séance du 17 décembre 2020 a constaté l’absence d’évaluation médico-économique du produit COREVALVE EVOLUT R & EVOLUT PRO sur les dépenses de l’assurance maladie.
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
9D73WwjhUPAgDybc
